Home/Filings/4/0000899243-20-020389
4//SEC Filing

Bhagat Sarah M 4

Accession 0000899243-20-020389

CIK 0001693011other

Filed

Jul 23, 8:00 PM ET

Accepted

Jul 24, 4:43 PM ET

Size

5.5 KB

Accession

0000899243-20-020389

Insider Transaction Report

Form 4
Period: 2020-07-23
Transactions
  • Award

    Stock Option (right to buy)

    2020-07-23+9,3679,367 total
    Exercise: $16.00Exp: 2030-07-22Common Stock (9,367 underlying)
Footnotes (1)
  • [F1]The option was granted on July 23, 2020. The shares underlying the option are scheduled to vest as to 100% of the shares on July 23, 2021, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.

Issuer

Inozyme Pharma, Inc.

CIK 0001693011

Entity typeother

Related Parties

1
  • filerCIK 0001817762

Filing Metadata

Form type
4
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:43 PM ET
Size
5.5 KB